Well-differentiated neuroendocrine tumors in skin: Terminology and diagnostic utility of cytokeratin 5/6 and p63 Journal Article


Authors: Panse, G.; Cowper, S. E.; Leffell, D. J.; Pulitzer, M.; Ko, C. J.
Article Title: Well-differentiated neuroendocrine tumors in skin: Terminology and diagnostic utility of cytokeratin 5/6 and p63
Abstract: Background: Well-differentiated neuroendocrine tumors (WDNETs) in skin include metastases from visceral primary sites and very uncommonly, primary cutaneous carcinoid tumors. Cutaneous WDNET may present a diagnostic challenge and in particular can be mistaken for a benign skin adnexal tumor. In contrast to cutaneous adnexal tumors, metastatic adenocarcinomas to the skin are cytokeratin 5/6 (CK5/6) and p63 negative in the majority of cases. It is unclear if failure to stain with CK5/6 and p63 would be helpful in differentiating WDNETs from cutaneous adnexal neoplasms. Methods: We reviewed 10 cases of cutaneous WDNETs (8 cases of metastatic disease and 2 presumed primary carcinoid tumors of the skin) and performed immunohistochemical stains for CK5/6 and p63 on all cases. Results: All 10 cases were negative with both CK5/6 and p63. Conclusion: Negative staining for CK5/6 and p63 can be helpful to distinguish WDNETs from cutaneous adnexal neoplasms. It is important to consider WDNETs in the differential diagnosis of cutaneous adnexal neoplasms as low-grade tumors may be the first sign of aggressive metastatic disease. © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Keywords: p63; ck5/6; cutaneous carcinoid; well-differentiated neuroendocrine tumor
Journal Title: Journal of Cutaneous Pathology
Volume: 44
Issue: 6
ISSN: 0303-6987
Publisher: John Wiley & Sons  
Date Published: 2017-06-01
Start Page: 557
End Page: 562
Language: English
DOI: 10.1111/cup.12952
PROVIDER: scopus
PUBMED: 28417484
DOI/URL:
Notes: Article -- Export Date: 3 July 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Melissa P Pulitzer
    203 Pulitzer